These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23951180)

  • 1. Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.
    Brand TM; Iida M; Luthar N; Wleklinski MJ; Starr MM; Wheeler DL
    PLoS One; 2013; 8(8):e71518. PubMed ID: 23951180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression.
    Han W; Sfondouris ME; Semmes EC; Meyer AM; Jones FE
    Gene; 2016 Oct; 592(1):221-226. PubMed ID: 27502417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways.
    Choi BK; Cai X; Yuan B; Huang Z; Fan X; Deng H; Zhang N; An Z
    Protein Cell; 2012 Oct; 3(10):781-9. PubMed ID: 22983903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of cyclin D1 via HER2/HER3 contributes to EGFR-TKI resistance in lung cancer.
    Liu B; Chen D; Chen S; Saber A; Haisma H
    Biochem Pharmacol; 2020 Aug; 178():114095. PubMed ID: 32535106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
    Guillemot L; Levy A; Raymondjean M; Rothhut B
    J Biol Chem; 2001 Oct; 276(42):39394-403. PubMed ID: 11502738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF.
    Andrique L; Fauvin D; El Maassarani M; Colasson H; Vannier B; Séité P
    Cell Signal; 2012 May; 24(5):1074-85. PubMed ID: 22261253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.
    Lee L; Ramos-Alvarez I; Moody TW; Mantey SA; Jensen RT
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118625. PubMed ID: 31862538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
    Monsey J; Shen W; Schlesinger P; Bose R
    J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations.
    Littlefield P; Liu L; Mysore V; Shan Y; Shaw DE; Jura N
    Sci Signal; 2014 Dec; 7(354):ra114. PubMed ID: 25468994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
    Venkatesh LK; Chinnadurai G
    J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
    Métivier R; Petit FG; Valotaire Y; Pakdel F
    Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein.
    Shen G; Hebbar V; Nair S; Xu C; Li W; Lin W; Keum YS; Han J; Gallo MA; Kong AN
    J Biol Chem; 2004 May; 279(22):23052-60. PubMed ID: 15020583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism.
    Boulon S; Dantonel JC; Binet V; Vié A; Blanchard JM; Hipskind RA; Philips A
    Mol Cell Biol; 2002 Nov; 22(22):7769-79. PubMed ID: 12391146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3.
    Shankaran H; Zhang Y; Tan Y; Resat H
    PLoS Comput Biol; 2013; 9(8):e1003201. PubMed ID: 23990774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.
    Zhang Y; Opresko L; Shankaran H; Chrisler WB; Wiley HS; Resat H
    BMC Cell Biol; 2009 Oct; 10():78. PubMed ID: 19878579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
    Gregory CW; Whang YE; McCall W; Fei X; Liu Y; Ponguta LA; French FS; Wilson EM; Earp HS
    Clin Cancer Res; 2005 Mar; 11(5):1704-12. PubMed ID: 15755991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
    Menendez JA; Lupu R
    Breast Cancer Res; 2007; 9(5):111. PubMed ID: 17983482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface.
    Collier TS; Diraviyam K; Monsey J; Shen W; Sept D; Bose R
    J Biol Chem; 2013 Aug; 288(35):25254-25264. PubMed ID: 23843458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.